A paradigm shift and a few modest suggestions in the care of adolescent transplant recipients

Transplantation

Volumn 92, Issue 11, 2011, Pages 1191-1193

  Ettenger, Robert B ^a   Tsai, Eileen W ^a   Fine, Richard N ^b  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELATACEPT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

AGE; CHILD BEHAVIOR; CHILD CARE; CHILD DEVELOPMENT; CHILD HEALTH CARE; CHILD PSYCHOLOGY; CONTINUING EDUCATION; FAMILY LIFE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; INDIVIDUALITY; INDIVIDUALIZATION; KIDNEY TRANSPLANTATION; MEDICAL RESEARCH; MEDICAL SPECIALIST; NOTE; PATIENT COMPLIANCE; PATIENT MONITORING; PEER PRESSURE; PRIORITY JOURNAL; SELF REPORT;

AGING; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; TRANSPLANTATION;

EID: 81855169724     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318238da81     Document Type: Note

References (25)

1. North American Pediatric Renal Trials and Collaborative Studies: 2010 Annual Transplant Report. Available at: www.emmes.com/study/ped/annlrept/2010- Report.pdf. Accessed November 7, 2011.
2. Smith JM, Ho PL, McDonald RA. Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002; 6: 493.
3. Gjertson DW, Cecka JM. Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry. Pediatr Transplant 2001; 5: 5.
4. Foster BJ, Dahhou M, Zhang X, et al. Association between age and graft failure rates in young kidney transplant recipients. Transplantation 2011; 92: 1237.
5. Rianthavorn P, Ettenger R, Malekzadeh M, et al. Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants. Transplantation 2004; 77: 778.
6. Welsh RM, Selin LK. No one is naive: The significance of heterologous T-cell immunity. Nat Rev Immunol 2002; 2: 417.
7. Adams AB, Pearson TC, Larsen CP. Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 2003; 196: 147.
8. Rehermann B, Shin EC. Private aspects of heterologous immunity. J Exp Med 2005; 201: 667.
9. Welsh RM. Private specificities of heterologous immunity. Curr Opin Immunol 2006; 18: 331.
10. Koelle DM, Chen HB, McClurkan CM. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte cross-reactivity against prevalent HLA class I alleles. Blood 2002; 99: 3844.
11. Watson AR. Non-compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 2000; 14: 469.
12. Office USGA. End-stage renal disease characteristics of kidney transplant recipients, frequency of transplant failures, and cost to medicare: Report to congressional requesters. 2007. Available at: www.gao.gov/new.items/d071117.pdf. Accessed November 7, 2011.
13. Dobbels F, Ruppar T, DeGeest S, et al. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 2010; 14: 603.
14. van den Heuvel ME, van der Lee JH, Cornelissen EA, et al. Transition to the adult nephrologist does not induce acute renal transplant rejection. Nephrol Dial Transplant 2010; 25: 1662.
15. Stuber ML, Shemesh E, Seacord D, et al. Evaluating non-adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant 2008; 12: 284.
16. Hsiau M, Fernandez HE, Gjertson D, et al. Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. Transplantation 2011; 92: 918.
17. Nickerson P. Post-transplant monitoring of renal allografts: Are we there yet? Curr Opin Immunol 2009; 21: 563.
18. Al-Ismaili Z, Palijan A, Zappitelli M. Biomarkers of acute kidney injury in children: Discovery, evaluation, and clinical application. Pediatr Nephrol 2011; 26: 29.
19. Smith JM, Corey L, Bittner R, et al. Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation. J AM Soc Nephrol 2010; 21: 1579.
20. Larsen CP, Grinyo J, Medina-Pestana J, et al. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation 2010; 90: 1528.
21. Bishop GA, Ierino FL, Sharland AF, et al. Approaching the promise of operational tolerance in clinical transplantation. Transplantation 2011; 91: 1065.
22. Samuel SM, Nettel-Aguirre A, Hemmelgarn BR, et al. Graft failure and adaptation period to adult healthcare centers in pediatric renal transplant patients. Transplantation 2011; 91: 1380.
23. Watson AR, Harden PN, Ferris ME, et al. Transition from pediatric to adult renal services: A consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol. 2011; 26: 1753.
24. Annunziato RA, Emre S, Shneider BL, et al. Transitioning health care responsibility from caregivers to patient: A pilot study aiming to facilitate medication adherence during this process. Pediatr Transplant 2008; 12: 309.
25. Pai AL, Gray E, Kurival K, et al. The Allocation of Treatment Responsibility scale: A novel tool for assessing patient and caregiver management of pediatric medical treatment regimens. Pediatr Transplant 2010; 14: 993.